Wealthspring Capital’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Wealthspring Capital’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36,750	Closed	-$385K	–	111
2023 Q1	$385K	Hold	36,750	–	–	0.63%	45
2022 Q4	$376K	Sell	36,750 -149,141	-80%	-$1.52M	0.56%	56
2022 Q3	$1.87M	Sell	185,891 -57,500	-24%	-$576K	0.37%	71
2022 Q2	$2.42M	Buy	243,391 +54,726	+29%	+$547K	0.46%	43
2022 Q1	$1.88M	Buy	188,665 +3,995	+2%	+$39.9K	0.37%	63
2021 Q4	$1.85M	Buy	+184,670	New	+$1.85M	0.4%	66

Other funds holding BIOSU

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Wealthspring Capital's BIOSU Position: Q2 2023 in Review

Wealthspring Capital sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2023, closing a stake of 36,750 shares — an estimated $385K sold.

Wealthspring Capital first reported a position in BIOSU in Q4 2021 and held it in 6 quarters. The position peaked at $2.42M in Q2 2022. 2 funds tracked by Wall St. Rank hold BIOSU as of Q2 2023.

Wealthspring Capital reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Wealthspring Capital sold 36,750 BioPlus Acquisition Corp. Unit shares in Q2 2023, an estimated $385K.
Wealthspring Capital first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Wealthspring Capital's BioPlus Acquisition Corp. Unit position peaked at $2.42M in Q2 2022.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2023.

Based on Wealthspring Capital's 13F filing for Q2 2023, filed 24 Jul 2023.